Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
Ryan Kahn, Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Sia, Anna Maio, Yelena Kemel, Margaret Sheehan, Erin Salo‐Mullen, Kelsey Breen, Qin Zhou, Alexia Iasonos, Rachel N. Grisham, Roisin E. O’Cearbhaill, S. Dennis, Michael F. Berger, Ritika Kundra, Nikolaus Schultz, Lora H. Ellenson, Zsofia K. Stadler, Kenneth Offit, Diana Mandelker, Carol Aghajanian, Dmitriy Zamarin, Paul Sabbatini, Britta Weigelt, Ying L. Liu
Topics & Concepts
Homologous recombinationGermlineOvarian cancerHomologous chromosomeGenePhenotypeGeneticsGermline mutationRecombinationMedicineCancer researchBiologyCancerMutationBRCA gene mutations in cancerPARP inhibition in cancer therapyOvarian cancer diagnosis and treatment